MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,902,040 | +40.8% | 990,204 | +75.1% | 0.00% | +100.0% |
| Q2 2023 | $7,030,856 | -38.9% | 565,636 | -31.1% | 0.00% | -50.0% |
| Q1 2023 | $11,500,626 | +0.8% | 820,887 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $11,409,020 | -14.3% | 797,276 | +53.0% | 0.00% | -33.3% |
| Q3 2022 | $13,307,000 | +0.6% | 521,221 | +12.0% | 0.00% | 0.0% |
| Q2 2022 | $13,223,000 | -23.0% | 465,429 | -4.4% | 0.00% | 0.0% |
| Q1 2022 | $17,177,000 | -15.8% | 487,007 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $20,402,000 | -11.2% | 486,916 | +4.0% | 0.00% | -25.0% |
| Q3 2021 | $22,974,000 | -22.0% | 468,076 | -33.6% | 0.00% | -20.0% |
| Q2 2021 | $29,436,000 | +138.7% | 705,386 | +103.9% | 0.01% | +150.0% |
| Q1 2021 | $12,331,000 | – | 345,996 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |